Log in to your Inderes Free account to see all free content on this page.

Vitrolife

105.00 SEK

+0.67%

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue960.03,609.0842.0871.0835.0892.03,440.0807.0
EBITDA337.0962.0257.0243.0253.0196.0949.0251.0
EBIT224.0783.0151.0137.0144.0-5,267.0-4,835.0149.0
EBIT-%23.3 %21.7 %17.9 %15.7 %17.2 %-590.5 %-140.6 %18.5 %
Profit before taxes183.0674.0141.0132.0131.0-5,290.0-4,886.0130.0
Net income140.0514.0100.0100.0102.0-5,315.0-5,013.0101.0
Login required

This content is only available for logged in users